In this study, we aimed to investigate the role of LAT2/glutamine in gemcitabine resistance and the therapeutic potential of curcumin, especially for improvement of gemcitabine treatment using both in vitro and in vivo models of gemcitabine-resistant CCA. Here, LAT2 is linked to cholangiocarcinoma.